Seeking enlightenment, FDA plans to visit vape factories

The US Food and Drug Administration (FDA) plans to visit vapour manufacturers in an effort to better understand the development, manufacturing, and testing of electronic delivery nicotine systems, as it pushes forward in its regulation of the category.

It said that in 2020 its employees will tour “five or fewer” facilities that make vaping products and e-liquids, including pods and cartridges, and it is looking for facilities of “different sizes” to host these visits.

Specifically, it wants to examine facilities that can “demonstrate assembly process and present supply chain information, and laboratories that conduct ENDS aerosol and e-liquid testing”.

Read full article
I'm already a subscriber
Author default picture

Daniel Mollenkamp

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization